• 1
    Senofsky GM, Moffat FL, Davis K, Masri MM, Clark KC, Robinson DS, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991; 126: 133642.
  • 2
    Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985; 72: 3689.
  • 3
    Seigel BM, Mayzel KA, Love SM. Level 1 and 2 axillary dissection in the treatment of early stage breast cancer: an analysis of 259 consecutive patients. Arch Surg 1990; 125: 11447.
  • 4
    Silverstein MJ, Rosser RJ, Gierson ED, Gamagami P, Colburn WJ, Handel N, et al. Axillary lymph node dissection for intraductal carcinoma: is it indicated [abstract]? Proc Am Soc Clin Oncol 1986; 5: 265.
  • 5
    Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Gamagami P, Hoffman RS, et al. Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer 1987; 59: 181924.
  • 6
    Silverstein MJ, Waisman JR, Colburn WJ, Furmanski M, Lewinsky BS, Cohlan BF, et al. Intraductal breast carcinoma (DCIS) with and without microinvasion (Mi): is there a difference in outcome [abstract]? Proc Am Soc Clin Oncol 1993; 12: 56.
  • 7
    Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990; 125: 12981302.
  • 8
    BearsOH, HensonDE, HutterRVP, KennedyBJ, editors. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott 1992: 14954.
  • 9
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 45781.
  • 10
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 16370.
  • 11
    Gehan EA. A generalized Wilcoxon test for comparing arbitrary singly-censored samples. Biometrica 1965; 52: 20323.
  • 12
    Lagios MD. Duct carcinoma in situ, biology, grading, and microinvasion. In: TavassoliFA, FechnerRE, LagiosMD, PageDL, SchnittSJ, editors. Proceedings, Current Problems in Breast Pathology; 1993 April 19–21; La Jolla, CA. American Society of Clinical Pathologists Educational Course.
  • 13
    Tavassoli FA. Infiltrating carcinomas, common and familiar special types. In: TavassoliFA, editor. Pathology of the breast. Norwalk, CT: Appleton and Lange, 1992: 293347.
  • 14
    Page DL, Anderson TJ. Miscellaneous features of carcinoma. In: PageDL, AndersonTJ, editors. Diagnostic histopathology of the breast. London: Churchill Livingstone, 1987: 26999.
  • 15
    Fisher B. The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal. Curr Probl Surg 1970; Oct.: 153.
  • 16
    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 67481.
  • 17
    Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5: 1721.
  • 18
    Hellman S, Harris JR. The appropriate breast cancer paradigm. Cancer Res 1987; 2: 33942.
  • 19
    Fisher B, Montague E, Redmond C, Barton B, Borland D, Fisher ER, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1977; 39: 282739.
  • 20
    Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978; 41: 11708.
  • 21
    Nemoto T, Vana J. Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980; 45: 291724.
  • 22
    Fisher B, Slack N, Katrych D, Wolmark N. Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 1975; 140: 52834.
  • 23
    Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30(1): 187210.
  • 24
    Ciatto S, Cecchini S, Lossa A, Grazzini G, Bravetti P, Rosselli M, et al. Prognosis of nonpalpable infiltrating carcinoma of the breast. Surg Gynecol Obstet 1990; 170: 614.
  • 25
    Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in Stage I (T1N0M0) breast carcinoma. J Clin Oncol 1989; 7: 35566.